Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Ocera Therapeutics (OCRX)

1.2529 +0.0029 (+0.2320%)

4/25/2017  12:11pm

Open:

1.2700

Pre. Close:

1.2500

High:

1.2900

Low:

1.2500

Volume:

132,116

Market Cap:

29.57M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.35 - 1.37

1.37 - 1.4

Low:

1.16 - 1.18

1.18 - 1.21

Close:

1.21 - 1.25

1.25 - 1.3

Technical analysis  (as of: 2017-04-25 12:07:33 PM)

Overall:

      

Stoxline posted a SELL today, upgraded from strong sell. But this stock still is very strong for short side. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 1.68     One year: 1.89

Support:

Support1: 1.14    Support2: 0.95

Resistance:

Resistance1: 1.44    Resistance2: 1.62

Pivot:

1.27

Moving Averages:

MA(5): 1.30     MA(20): 1.28

MA(100): 1.48     MA(250): 2.08

MACD:

MACD(12,26): 0.03     Signal(12,26,9): 0.04

%K %D:

%K(14,3): 26.74     %D(3): 32.99

RSI:

RSI(14): 49.76

52-Week:

High: 3.1800  Low: 0.5200  Change(%): -58.4

Average Vol(K):

3-Month: 3281  10-Days 1627

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
OCRX has closed above bottom band by 43.2%. Bollinger Bands are 60.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to OCRX's normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 10 Mar 2017 22:07:30 GMT
Ocera Therapeutics: Major Risk, Great Upside Potential

Tue, 25 Apr 2017 11:03:45 GMT
Price Objective Update on Ocera Therapeutics, Inc. (NASDAQ:OCRX)

Tue, 25 Apr 2017 14:03:45 GMT
Ocera Therapeutics Inc (OCRX) Receives Consensus Rating of "Buy" from Analysts

Wed, 12 Apr 2017 21:29:05 GMT
Ocera Therapeutics Inc (OCRX) Shares Rally Amid Positive Preclinical Data In ...

Wed, 08 Feb 2017 20:23:15 GMT
What Sell-Side Analysts Think About Ocera Therapeutics Inc (OCRX) Following ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

23.60

Shares Float (M)

15.98

% Held by Insiders

41.36

% Held by Institutions

29.90

Shares Short (K)

2450

Shares Short Prior Month (K)

980

Stock Financials

EPS

-1.230

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

0.670

PEG Ratio

Profit Margin

Operating Margin

-4249.59

Return on Assets (ttm)

-43.5

Return on Equity (ttm)

-114.1

Qtrly Rev. Growth

2033.3

Gross Profit (p.s.)

0.026

Sales Per Share

0.026

EBITDA (p.s.)

-1.095

Qtrly Earnings Growth

Operating Cash Flow (M)

-22.10

Levered Free Cash Flow (M)

-12.27

FoxReading.com

Valuation

P/E

-1.02

P/E Growth Ratio

P/BV

1.87

P/S

48.63

P/CF

-1.34

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2013-07-16

Last Split Ratio

0.083

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.